Literature DB >> 25175604

Activation of Wnt/β-catenin signaling in a subpopulation of murine prostate luminal epithelial cells induces high grade prostate intraepithelial neoplasia.

Kenneth C Valkenburg1, Xiuping Yu, Angelo M De Marzo, Tyler J Spiering, Robert J Matusik, Bart O Williams.   

Abstract

BACKGROUND: Wnt/β-catenin signaling is important for prostate development and cancer in humans. Activation of this pathway in differentiated luminal cells of mice induces high-grade prostate intraepithelial neoplasia (HGPIN). Though the cell of origin of prostate cancer has yet to be conclusively identified, a castration-resistant Nkx3.1-expressing cell (CARN) may act as a cell of origin for prostate cancer.
METHODS: To activate Wnt/β-catenin signaling in CARNs, we crossed mice carrying tamoxifen-inducible Nkx3.1-driven Cre to mice containing loxP sites in order to either conditionally knock out adenomatous polyposis coli (Apc) or constitutively activate β-catenin directly. We then castrated and hormonally regenerated these mice to target the CARN population.
RESULTS: Loss of Apc in hormonally normal mice induced HGPIN; however, after one or more rounds of castration and hormonal regeneration, Apc-null CARNs disappeared. Alternatively, when β-catenin was constitutively activated under the same conditions, HGPIN was apparent.
CONCLUSION: Activation of Wnt/β-catenin signaling via Apc deletion is sufficient to produce HGPIN in hormonally normal mice. Loss of Apc may destabilize the CARN population under regeneration conditions. When β-catenin is constitutively activated, HGPIN occurs in hormonally regenerated mice. A second genetic hit is likely required to cause progression to carcinoma and metastasis.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Apc; CARNs; Nkx3.1; Wnt; beta-catenin; mouse model

Mesh:

Substances:

Year:  2014        PMID: 25175604      PMCID: PMC4175140          DOI: 10.1002/pros.22868

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  44 in total

1.  TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway.

Authors:  Qun-Ying Lei; Heng Zhang; Bin Zhao; Zheng-Yu Zha; Feng Bai; Xin-Hai Pei; Shimin Zhao; Yue Xiong; Kun-Liang Guan
Journal:  Mol Cell Biol       Date:  2008-01-28       Impact factor: 4.272

2.  Role of TAZ as mediator of Wnt signaling.

Authors:  Luca Azzolin; Francesca Zanconato; Silvia Bresolin; Mattia Forcato; Giuseppe Basso; Silvio Bicciato; Michelangelo Cordenonsi; Stefano Piccolo
Journal:  Cell       Date:  2012-12-13       Impact factor: 41.582

Review 3.  Wnt signalling and prostate cancer.

Authors:  G W Yardy; S F Brewster
Journal:  Prostate Cancer Prostatic Dis       Date:  2005       Impact factor: 5.554

Review 4.  APC gene hypermethylation and prostate cancer: a systematic review and meta-analysis.

Authors:  Yang Chen; Jie Li; Xiaoxiang Yu; Shuai Li; Xuerong Zhang; Zengnan Mo; Yanling Hu
Journal:  Eur J Hum Genet       Date:  2013-01-09       Impact factor: 4.246

5.  Estrogen-initiated transformation of prostate epithelium derived from normal human prostate stem-progenitor cells.

Authors:  Wen-Yang Hu; Guang-Bin Shi; Hung-Ming Lam; Dan-Ping Hu; Shuk-Mei Ho; Ikenna C Madueke; Andre Kajdacsy-Balla; Gail S Prins
Journal:  Endocrinology       Date:  2011-03-22       Impact factor: 4.736

Review 6.  Molecular genetics of prostate cancer: new prospects for old challenges.

Authors:  Michael M Shen; Cory Abate-Shen
Journal:  Genes Dev       Date:  2010-09-15       Impact factor: 11.361

7.  Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis.

Authors:  Minjung J Kim; Robert D Cardiff; Nishita Desai; Whitney A Banach-Petrosky; Ramon Parsons; Michael M Shen; Cory Abate-Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

8.  Expression of Foxa transcription factors in the developing and adult murine prostate.

Authors:  Janni Mirosevich; Nan Gao; Robert J Matusik
Journal:  Prostate       Date:  2005-03-01       Impact factor: 4.104

9.  Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications.

Authors:  Gaoping Chen; Nicholas Shukeir; Anil Potti; Kanishka Sircar; Armen Aprikian; David Goltzman; Shafaat A Rabbani
Journal:  Cancer       Date:  2004-09-15       Impact factor: 6.860

10.  Gene expression profiling identifies clinically relevant subtypes of prostate cancer.

Authors:  Jacques Lapointe; Chunde Li; John P Higgins; Matt van de Rijn; Eric Bair; Kelli Montgomery; Michelle Ferrari; Lars Egevad; Walter Rayford; Ulf Bergerheim; Peter Ekman; Angelo M DeMarzo; Robert Tibshirani; David Botstein; Patrick O Brown; James D Brooks; Jonathan R Pollack
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-07       Impact factor: 11.205

View more
  10 in total

Review 1.  Mini-review: Does Notch promote or suppress cancer? New findings and old controversies.

Authors:  Irina B Grishina
Journal:  Am J Clin Exp Urol       Date:  2015-04-25

Review 2.  Genetically Engineered Mouse Models of Prostate Cancer in the Postgenomic Era.

Authors:  Juan M Arriaga; Cory Abate-Shen
Journal:  Cold Spring Harb Perspect Med       Date:  2019-02-01       Impact factor: 6.915

Review 3.  Drug discovery in prostate cancer mouse models.

Authors:  Kenneth C Valkenburg; Kenneth J Pienta
Journal:  Expert Opin Drug Discov       Date:  2015-06-01       Impact factor: 6.098

Review 4.  Somatic Mutations in Prostate Cancer: Closer to Personalized Medicine.

Authors:  M J Alvarez-Cubero; L J Martinez-Gonzalez; I Robles-Fernandez; J Martinez-Herrera; G Garcia-Rodriguez; M Pascual-Geler; J M Cozar; J A Lorente
Journal:  Mol Diagn Ther       Date:  2017-04       Impact factor: 4.074

5.  Paracrine Wnt signaling is necessary for prostate epithelial proliferation.

Authors:  Xing Wei; Martine P Roudier; Oh-Joon Kwon; Justin Daho Lee; Kevin Kong; Ruth Dumpit; Lawrence True; Colm Morrissey; Daniel W Lin; Peter S Nelson; Li Xin
Journal:  Prostate       Date:  2022-01-11       Impact factor: 4.104

6.  miR-425-5p suppresses tumorigenesis and DDP resistance in human-prostate cancer by targeting GSK3β and inactivating the Wnt/β-catenin signaling pathway.

Authors:  Sheng Liu; Qin Wang; Yin Liu; Zong-Yu Xia
Journal:  J Biosci       Date:  2019-09       Impact factor: 1.826

7.  Murine Prostate Micro-dissection and Surgical Castration.

Authors:  Kenneth C Valkenburg; Sarah R Amend; Kenneth J Pienta
Journal:  J Vis Exp       Date:  2016-05-11       Impact factor: 1.355

Review 8.  Type II transmembrane serine proteases as potential targets for cancer therapy.

Authors:  Andrew S Murray; Fausto A Varela; Karin List
Journal:  Biol Chem       Date:  2016-09-01       Impact factor: 3.915

Review 9.  Exploring the Wnt Pathway as a Therapeutic Target for Prostate Cancer.

Authors:  Sarah Koushyar; Valerie S Meniel; Toby J Phesse; Helen B Pearson
Journal:  Biomolecules       Date:  2022-02-15

10.  Deletion of tumor suppressors adenomatous polyposis coli and Smad4 in murine luminal epithelial cells causes invasive prostate cancer and loss of androgen receptor expression.

Authors:  Kenneth C Valkenburg; Angelo M De Marzo; Bart O Williams
Journal:  Oncotarget       Date:  2017-05-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.